Analysis of maternal and fetal cardiovascular systems during hyperglycemic pregnancy in the nonobese diabetic mouse

Biology of Reproduction

Volumn 88, Issue 6, 2013, Pages

  Aasa, Kristiina L ^a   Kwong, Kenneth K ^a   Adams, Michael A ^a   Croy, B Anne ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cardiac adaptations; Cardiovascular; Cardiovascular system; Developmental origins of health and disease; Diabetes; NOD mouse; Pregnancy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS WASTAGE; GESTATIONAL AGE; GLYCEMIC CONTROL; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HISTOPATHOLOGY; HYPERGLYCEMIA; MOTHER FETUS RELATIONSHIP; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; UMBILICAL CORD;

CARDIAC ADAPTATIONS; CARDIOVASCULAR; CARDIOVASCULAR SYSTEM; DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE; DIABETES; NOD MOUSE; PREGNANCY;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; ECHOCARDIOGRAPHY; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; HEART; KIDNEY; MICE; MICE, INBRED NOD; PREGNANCY; RISK FACTORS; VENTRICULAR REMODELING;

EID: 84882256091     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.105759     Document Type: Article

References (45)

1. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352:2477-2486.
2. Hay WW Jr. Care of the infant of the diabetic mother. Curr Diab Rep 2012; 12:4-15.
3. Vambergue A, Fajardy I. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes 2011; 2: 196-203.
4. Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF. The diabetic cardiomyopathy. Acta Diabetol 2011; 48:173-181.
5. Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test. Ther Adv Cardiovasc Dis 2008; 2:249-259.
6. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68:540-543.
7. Desai DK, Moodley J, Naidoo DP. Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy. Obstet Gynecol 2004; 104:20-29.
8. Tsiaras S, Poppas A. Cardiac disease in pregnancy: value of echocardiography. Curr Cardiol Rep 2010; 12:250-256.
9. Burke SD, Barrette VF, Carter AL, Gravel J, Adams MA, Croy BA. Cardiovascular adaptations of pregnancy in T and B cell-deficient mice. Biol Reprod 2011; 85:605-614.
10. Kitzmiller JL, Dang-Kilduff L, Taslimi MM. Gestational diabetes after delivery. Short-term management and long-term risks. Diabetes Care 2007; 30(suppl 2):S225-S235.
11. Simeoni U, Barker DJ. Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med 2009; 14:119-124.
12. Dawson SI. Glucose tolerance in pregnancy and the long-term risk of cardiovascular disease. Diabetes Res Clin Pract 2009; 85:14-19.
13. Haeri S, Khoury J, Kovilam O, Miodovnik M. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am J Obstet Gynecol 2008; 199: 278.e1-278.e5.
14. Burke SD, Dong H, Hazan AD, Croy BA. Aberrant endometrial features of pregnancy in diabetic NOD mice. Diabetes 2007; 56:2919-2926.
15. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004; 328:915.
16. Platt MJ, Stanisstreet M, Casson IF, Howard CV, Walkinshaw S, Pennycook S, McKendrick O. St Vincent's Declaration 10 years on: outcomes of diabetic pregnancies. Diabet Med 2002; 19:216-220.
17. Mongiovi M, Fesslova V, Fazio G, Barbaro G, Pipitone S. Diagnosis and prognosis of fetal cardiomyopathies: a review. Curr Pharm Des 2010; 16: 2929-2934.
18. Turan S, Turan OM, Miller J, Harman C, Reece EA, Baschat AA. Decreased fetal cardiac performance in the first trimester correlates with hyperglycemia in pregestational maternal diabetes. Ultrasound Obstet Gynecol 2011; 38:325-331.
19. Bunt JC, Tataranni PA, Salbe AD. Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children. J Clin Endocrinol Metab 2005; 90:3225-3229.
20. Burke SD, Barrette VF, David S, Khankin EV, Adams MA, Croy BA. Circulatory and renal consequences of pregnancy in diabetic NOD mice. Placenta 2011; 32:949-955.
21. Bucci M, Roviezzo F, Brancaleone V, Lin MI, Di Lorenzo A, Cicala C, Pinto A, Sessa WC, Farneti S, Fiorucci S, Cirino G. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arterioscler Thromb Vasc Biol 2004; 24:721-726.
22. Zimmerman MA, Haskins K, Bradley B, Gilman J, Gamboni-Robertson F, Flores SC. Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus. J Surg Res 2011; 168:e195-202.
23. Corrigan N, Brazil DP, McAuliffe F. Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol 2009; 85:523-530.
24. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, Cross JC. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002; 250:358-373.
25. Prophet EB, Armed Forces Institute of Pathology. Laboratory Methods in Histotechnology. Washington, DC: American Registry of Pathology; 1992.
26. Moon JY, Tanimoto M, Gohda T, Hagiwara S, Yamazaki T, Ohara I, Murakoshi M, Aoki T, Ishikawa Y, Lee SH, Jeong KH, Lee TW, et al. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KKA( y)/Ta mice. Am J Physiol Renal Physiol 2011; 300:F1271-F1282.
27. Wang H, Madhusudhan T, He T, Hummel B, Schmidt S, Vinnikov IA, Shahzad K, Kashif M, Muller-Krebs S, Schwenger V, Bierhaus A, Rudofsky G, et al. Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. Blood 2011; 117:5231-5242.
28. Ahokas RA, Sibai BM. The relationship between experimentally determined litter size and maternal blood pressure in spontaneously hypertensive rats. Am J Obstet Gynecol 1990; 162:841-847.
29. Otto CM, Pearlman AS. Textbook of Clinical Echocardiography. Philadelphia: WB Saunders; 1995.
30. Locatelli P, Olea FD, De Lorenzi A, Salmo F, Vera Janavel GL, Hnatiuk AP, Guevara E, Crottogini AJ. Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans. Int J Clin Exp Med 2011; 4:258-264.
31. Ogueh O, Clough A, Hancock M, Johnson MR. A longitudinal study of the control of renal and uterine hemodynamic changes of pregnancy. Hypertens Pregnancy 2011; 30:243-259.
32. Mu J, Adamson SL. Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation. Am J Physiol Heart Circ Physiol 2006; 291: H1421-H1428.
33. Gross V, Tank J, Partke HJ, Plehm R, Diedrich A, da Costa Goncalves AC, Luft FC, Jordan J. Cardiovascular autonomic regulation in non-obese diabetic (NOD) mice. Auton Neurosci 2008; 138:108-113.
34. Airaksinen KE, Ikaheimo MJ, Salmela PI, Kirkinen P, Linnaluoto MK, Takkunen JT. Impaired cardiac adjustment to pregnancy in type I diabetes. Diabetes Care 1986; 9:376-383.
35. Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2005; 90:3983-3988.
36. Katz AM. Ernest Henry Starling, his predecessors, and the "Law of the Heart." Circulation 2002; 106:2986-2992.
37. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal- Ginard B, Anversa P. Myocardial cell death in human diabetes. Circ Res 2000; 87:1123-1132.
38. Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Lab Invest 2000; 80:513-527.
39. Malhotra A, Vashistha H, Yadav VS, Dube MG, Kalra SP, Abdellatif M, Meggs LG. Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis. Am J Physiol Heart Circ Physiol 2009; 296:H380-H388.
40. Debrah DO, Novak J, Matthews JE, Ramirez RJ, Shroff SG, Conrad KP. Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinology 2006; 147:5126-5131.
41. Acharya G, Wilsgaard T, Berntsen GK, Maltau JM, Kiserud T. Dopplerderived umbilical artery absolute velocities and their relationship to fetoplacental volume blood flow: a longitudinal study. Ultrasound Obstet Gynecol 2005; 25:444-453.
42. Byun YJ, Kim HS, Yang JI, Kim JH, Kim HY, Chang SJ. Umbilical artery Doppler study as a predictive marker of perinatal outcome in preterm small for gestational age infants. Yonsei Med J 2009; 50:39-44.
43. Corrigan N, Treacy A, Brazil DP, McAuliffe FM. Cardiomyopathy and diastolic dysfunction in the embryo and neonate of a type 1 diabetic mouse model. Reprod Sci 2013; 20:781-790.
44. Holmes VA, Young IS, Patterson CC, Pearson DW, Walker JD, Maresh MJ, McCance DR. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 2011; 34:1683-1688.
45. Mathiesen ER, Ringholm L, Damm P. Pregnancy management of women with pregestational diabetes. Endocrinol Metab Clin North Am 2011; 40: 727-738.